.png){kind=icon}
.png){kind=icon}
Return
Environmental behavior, risks, and management of antidepressants in the aquatic environment
.png){kind=icon}
PRE
AI
Y
J
郭
D
J
DOI：10.1039/d4em00793j.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Antidepressants are increasingly detected in aquatic environments due to their incomplete removal in wastewater treatment, raising significant concerns about their ecological impacts. This review focuses on the three most widely used classes of antidepressants-tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), and serotonin-norepinephrine reuptake inhibitors (SNRIs). It systematically explores their physicochemical properties and how these properties influence their environmental fate, including sorption, mobility, and bioaccumulation in aquatic ecosystems. The sublethal effects of these antidepressants on aquatic organisms, particularly their impacts on behavior, reproduction, and development, are critically analyzed, highlighting potential threats to biodiversity and ecological stability. Key knowledge gaps are identified, including the long-term impacts of chronic low-dose exposure, the role of bioactive metabolites, and the combined toxicity of antidepressants with other contaminants. The review underscores the importance of advanced wastewater treatment technologies, environmentally mindful prescribing practices, and public awareness campaigns as essential measures to mitigate these risks. By addressing these challenges, this study aims to inform future research and guide sustainable environmental management strategies.
Keywords:
WASTE-WATER TREATMENT
REUPTAKE INHIBITORS SSRIS
PERSONAL CARE PRODUCTS
PSYCHOACTIVE PHARMACEUTICALS
TREATMENT PLANTS
CHIRAL PHARMACEUTICALS
FISH
EXPOSURE
BIOACCUMULATION
VENLAFAXINE
Journal
E
IF:
3.9
Papers:
178
Citations:
8.1K
Organization
Cited Papers